Monthly Archives: July 2018

Today’s Research Reports on Stocks to Watch: Illumina and Okta

NEW YORK, NY / ACCESSWIRE / July 31, 2018 / Illumina shares broke out in after-hours trading on Monday after reporting second quarter results that beat on both the top and bottom line. Shares of Otka closed down almost 10% as it followed other tech stocks into the red, despite any news from the company itself.

RDI Initiates Coverage on:

Illumina, Inc.
https://www.rdinvesting.com/report/?ticker=ILMN

Okta, Inc.
https://www.rdinvesting.com/report/?ticker=OKTA

Illumina, Inc. shares closed down 3.95% yesterday but saw a 6.92% jump in after-hours trading after the company reported its second quarter financial report. The San Diego-based company which markets integrated systems for the analysis of genetic variation and biological function reported a profit of $1.41 a share. Adjusted earnings per share were $1.43 a share. Wall Street had been anticipating earnings per share of just $1.11. Revenue for the period of $830 million also surpassed the $787.6 million that analysts had been waiting for. For the full year, the company has forecast earnings in the range of $5.35 to $5.45 a share. “Driven by broad demand across applications, systems and geographies, revenue grew 25% from the second quarter of 2017, and we are now expecting revenue growth of approximately 20% for 2018,” said Francis deSouza, the company’s President and CEO. “Sequencing consumables, array consumables, and lab and other services each grew more than 30% compared to the second quarter of 2017, highlighting the growing interest in genomic information and its application to research, clinical and consumer markets.” The stock is up roughly 32% since the year started.

Access RDI’s Illumina, Inc. Research Report at:
https://www.rdinvesting.com/report/?ticker=ILMN

Okta, Inc. shares closed down 9.62% on Monday with about 4 million shares traded. The stock saw a big drop on no particular news perhaps following broader tech and growth stocks that saw losses. It was earlier in July that the leading independent provider of identity for the enterprise had said that it acquired ScaleFT in order to bring Zero Trust to the enterprise together by providing organizations with a framework to protect sensitive data, without compromising on experience. COO and co-founder of Okta, Frederic Kerrest, commented, “Companies have realized they can no longer trust their network and have to understand device security — instead of trusting everyone behind a firewall, now IT and security leaders must trust no one, inside or outside the organization. To help our customers increase security while also meeting the demands of the modern workforce, we’re acquiring ScaleFT to further our contextual access management vision — and ensure the right people get access to the right resources for the shortest amount of time. Zero Trust is the security paradigm for today’s threat landscape, and identity is the unifying component which makes it all possible. In order to implement Zero Trust the right way, organizations must move away from the static credentials and access controls, the antiquated approach of perimeter-based security, and instead focus on adaptive and context-aware controls to make better, continuous access decisions.”

Access RDI’s Okta, Inc. Research Report at:
https://www.rdinvesting.com/report/?ticker=OKTA

Our Actionable Research on Illumina, Inc. (NASDAQ: ILMN) and Okta, Inc. (NASDAQ: OKTA) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 507496

Pure Capital Announces Over 5% Ownership of Medigus Ltd. and Demands to Replace the Board of Directors

RAMAT GAN, ISRAEL / ACCESSWIRE / July 31, 2018 / Pure Capital announced today that it has completed the acquisition of 217,696 ADR’s of Medigus Ltd (MDGS) and now holds more than five percent of the company.

Upon the acquisition, and in accordance with Israeli regulations, Pure Capital sent a letter to Medigus’ Chief Executive Officer, Chairman of the board and the directors, calling for an immediate general assembly meeting of the shareholders of Medigus and the dismissal of the internal members of the board. The replacement nominees, led by Professor Benad Goldwasser, have been carefully vetted and were selected following a thorough due diligence process. Prof. Goldwasser is a urological surgeon, inventor, entrepreneur, venture capital investor and co-founder of Medinol Ltd., Israel’s most successful medical device Company, dedicated to the science of cardiovascular intervention.

In the letter, Pure Capital detailed previous actions by the Company’s management and board which have been harmful to shareholders including continual capital consolidations and capital raises under unfavorable terms. Furthermore, Pure Capital has requested that Medigus not execute disposition of the assets of the company, attempt to raise capital, or make public or private offerings until the meeting. Pure Capital is committed to fully replacing the internal members of the Board of Directors and substantially enhancing shareholder value in the process. The meeting is expected to be scheduled within the week.

Pure Capital Ltd. is a privately-owned investment company. Over the last two years, the firm has led various transactions and capital raises totaling over $200 million in the U.S, Canada and Israel.

Medigus (MDGS) is a medical device company specializing in developing minimally invasive endosurgical tools and highly innovative imaging solutions. Medigus is the pioneer developer of the MUSE™ system, an FDA-cleared and CE marked endoscopic device to perform Transoral Fundoplication (TF) for the treatment of GERD (gastroesophageal reflux disease), one of the most common chronic conditions in the world.

Contact Info:

Victor Tshuva, Victor Tshuva & Co Law Office
Tel: 011-972- 36138484
victor@vtlaw.co.il

SOURCE: Pure Capital Ltd.

ReleaseID: 507431

Wound Care Market Global Size 2018, Industry Analysis, Growth Drivers and Competitive Players by MRFR till 2023

Exclusively Available at MarketResearchFuture.com with titled Wound Care Market. By Major Industry Trends, Business Analysis, Major Segments and Sub segments. Along with this regional analysis of the market which includes Americas, Europe, Asia Pacific and Middle East & Africa.

Pune, India – July 31, 2018 /MarketersMedia/

Wound Care Market – Highlights:

Chronic wound treatment can be done through various wound care and closure products. The cases of chronic wounds patients have been increasing, so are the demands of wound care and closure.  According to the American Burn Association, in 2014, approximately 486,000 burn injuries were reported which boosted the market growth during the forecasted period. Moreover, rising per capita income, increasing prevalence of diabetes and other chronic diseases along with growing number of surgeries and development in the medical technology have boosted the market growth during the forecasted period. However, the high cost of advanced wound care products is expected to restrain the market growth. The global wound care market is expected to grow at a CAGR of 6.20% during the forecast period.

Get Premium Sample Copy of Wound Care Market Report spread across 90 Premium Pages, Top 10 Companies and Supported with 122 Tables and 21 Figures is Now Available at https://www.marketresearchfuture.com/sample_request/926 .

Wound Care Market – Key Players

Braun Melsungen

Baxter

Ethicon

Smith & Nephew

ConvaTec

Kinetic Concept

And others.

Wound Care Market – Segmentation:

The global wound care market is segmented on the basis of products, type, application, and end users.
On the basis of products, the market is segmented into advanced wound management products, wound therapy devices, traditional wound care products, wound care products, active wound care products, and others. The advanced wound management products segment is sub segmented into advanced wound dressings, foam dressings, hydrocell foam dressings, alginate dressings, hydrogel dressings, collagen dressings, others. The wound therapy devices segment is sub segmented into oxygen and hyperbaric oxygen equipment, negative pressure wound therapy device (NPWT), cutting-edge wound therapy device, electrical stimulation devices, and others. The wound care products segment is sub segmented into sutures, surgical staples, haemostats, wound care strips, adhesives and tissue sealants, and others. The active wound care products segment is sub segmented into topical agents, artificial skin and skin substitutes, and others.

On the basis of type, the market is categorised into chronic wounds, acute wounds, and others.

On the basis of application, the market is segmented surgical wounds, ulcers, burn, trauma wounds, and others.

On the basis of end users, the market is segmented into hospitals, clinics, home healthcare, trauma centers, and others.

Wound Care Market – Regional Analysis:

The Americas dominates the global wound care market owing to a well-developed healthcare sector and high per capita healthcare expenditures. Moreover, the presence of global players like 3M and Baxter in the developed economies like U.S and Canada within the region fuels the market growth.

Europe is the second largest market for wound care, which is followed by Asia Pacific. Availability of funds for research, high healthcare expenditures, huge patient population and government support for research & development will drive the market in the Europe. In the U.K,the cost to the National Health Service for caring for patients with chronic wounds was estimated to be around USD 3.4-4.6 billion per year.

Asia Pacific is the fastest growing region for the wound care market due to the presence of developing economies like India and China. This along with favorable government policies and rising healthcare expenditure boosted the market growth in the presence of huge opportunity for the untapped market within the region.

The Middle East & Africa has the least share in the global wound care market due to presence of poor economies especially in the African region. Majority of the market of Middle & Africa region is held by the Middle East due to a well-developed healthcare sector.

Get Prime Discount at https://www.marketresearchfuture.com/check-discount/926 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: sales@marketresearchfuture.com
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: +1 646 845 9312

Source URL: https://marketersmedia.com/wound-care-market-global-size-2018-industry-analysis-growth-drivers-and-competitive-players-by-mrfr-till-2023/387012

For more information, please visit https://www.marketresearchfuture.com/reports/wound-care-market-926

Source: MarketersMedia

Release ID: 387012

Home Healthcare Market 2018 Industry Overview, Likely to boost the Market Growth with CAGR of 8.1% by MRFR till 2023

Exclusively Available at MarketResearchFuture.com with titled Home Healthcare Market. By Major Industry Trends, Business Analysis, Major Segments and Sub segments. Along with this regional analysis of the market which includes Americas, Europe, Asia Pacific and Middle East & Africa.

Pune, India – July 31, 2018 /MarketersMedia/

Home Healthcare Market – Highlights:

In the coming years, the global economy will witness a sharp increase in the home health industry. The increased competition among existing and new market players to develop a device with higher accuracy and more advanced features will ultimately results in the growth of the market. Diabetes is one of the serious complications. So, most of the market players are focused to develop an efficient, and affordable blood glucose monitor, especially, for low income population. For instance, Abbott brought a flash glucose monitoring (FGM) system to the market i.e., Freestyle Libre. In contrast to the available CGM systems, the Freestyle Libre does not require calibration.

Rise in aging population, technological advancements, rising treatment cost and hospital stay, and rising approval from regulatory bodies are propelling the growth of the market. However, patient safety concerns may hinder the growth of market to an extent. Various issues have been found in home healthcare settings such as unsanitary conditions, medication errors, and others.

It is estimated that home healthcare market is expected to grow at a CAGR of 8.1% during the forecast period 2017-2023.

Get Premium Sample Copy of Home Healthcare Market Report spread across 85 Premium Pages, Top 10 Companies and Supported with 167 Tables and 14 Figures is Now Available at https://www.marketresearchfuture.com/sample_request/2030 .

Top Players:

Abbott

GE Healthcare

Becton Dickinson Company

Omron Corporation

Apple

Medtronic

Koninklijke Philips

LG Electronics and others.

Home Healthcare Market – Regional Analysis:

The Americas dominate the home healthcare market owing to the presence of geriatric population, the presence of the leading players, and high healthcare expenditure. According to the WHO, world’s population aged over 60 years will nearly double from 12% to 22% by 2050, and in the United States over 20% of the total population will be aged 65 years or over by 2030.

Europe holds the second position in the home healthcare market. It is expected that the support provided by the private, and government bodies for research & development, along with a well-developed technology drives the home healthcare market in the European region.

Home Healthcare Market – Segmentation:

The global home healthcare market is segmented on the basis of product, services, and software.

On the basis of product, the market is segmented into testing, screening, & monitoring products, and therapeutic products. The testing, screening, & monitoring products are further segmented into blood glucose monitors, blood pressure monitors, sleep apnea monitors, pulse oximeters & heart rate monitors, cholesterol monitoring devices, holter and event monitors, and others. The therapeutic products are further segmented into respiratory therapy equipment, insulin delivery devices, IV equipment, wound care products, dialysis equipment, others.

On the basis of services, the market is classified into skilled nursing services, rehabilitation therapy services, unskilled care services, respiratory therapy services, infusion therapy services, and pregnancy care services.

On the basis of software, the market is classified into clinical management systems, agency software, telehealth solution, and hospice solutions.

Major TOC of Home Healthcare Market Research Report – Global Forecast to 2023:

1 Executive Summary

2 Market Introduction

3 Research Methodology

4 Market Impact Analysis

5 Market Dynamics

6 Global Home Healthcare Market by Product

7 Global Home Healthcare Market by Services

8 Global Home Healthcare Market by Software

9 Global Home Healthcare Market by Region

10 Company Landscape

11 Company Profiles

Have Any Query, Ask to Experts at https://www.marketresearchfuture.com/enquiry/2030 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: sales@marketresearchfuture.com
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: +1 646 845 9312

Source URL: https://marketersmedia.com/home-healthcare-market-2018-industry-overview-likely-to-boost-the-market-growth-with-cagr-of-8-1-by-mrfr-till-2023/387011

For more information, please visit https://www.marketresearchfuture.com/reports/home-healthcare-market-2030

Source: MarketersMedia

Release ID: 387011

Cochlear Implants Market 2018 to Perceive Illustrious Growth USD 3,203.8 million with CAGR of 9.86% by 2023

Market Research Future published a cooked research report on “Cochlear Implants Market Research Report – By Major Industry Trends, Worldwide Business Analysis, Major Segments and Sub segments. Market Analysis, Scope, Stake, Progress and Forecast to 2023.

Pune, India – July 31, 2018 /MarketersMedia/

Cochlear Implants Market – Scenario

Cochlear implants are used to aid the hearing defects in patients with severe of total hearing impairment. These implant has replaced the old hearing aid devices. Cochlear implants are equipped with an external sound processor containing microphones, battery, electronics assembly and other parts. The device stimulate the cochlear nerve through the use of a coil. The cochlear implants market is anticipated to generate a CAGR growth of 9.86% which is expected to reach USD 3,203.8 million by the end of forecast period of 2023.

Global Cochlear Implants Market – Drivers:

Technological advances and product development are the two most successful strategies used by the market leaders.

Get Premium Sample Copy of Cochlear Implants Market Report spread across 83 Premium Pages, Top 10 Companies and Supported with 102 Tables and 19 Figures is Now Available at https://www.marketresearchfuture.com/sample_request/5256 .

The large number of patients suffering from hearing impairments is the critical driver of the market. It is estimated that in 2014, almost 360 million patients worldwide were suffering from serious hearing loss. According to the Centers for Disease Control and Prevention, by 2025, an estimated 900 million patients are likely to suffer from severe hearing impairment. Thus a large unmet need is easily comprehendible.

Other drivers of the market are rising geriatric population, and favorable reimbursement policies. According to the U.S. Census Bureau in 2015, 8.5% of people representing 617 million over age 65 years of age are suffering from hearing loss.

The growing demand for cochlear implants is the other driver of the market. According to the National Institute on Deafness and Other Communication Disorders estimates, approximately 324,200 registered devices were implanted in 2013 alone. Increasing healthcare expenditure and government support have fuelled the market growth.

Key players:

Advanced Bionics

MED-El

William Demant Holding Group

Widex

Microson.

Segments of Global Cochlear Implants Market:

The have a clear understanding of the market potential, the report has been segmented on the basis of products, types and end users.

Products – cochlear implant system, and accessories & upgrades.    The global cochlear implants market by products is dominated by the cochlear implant system.

Types – unilateral implant and bilateral implant.

End users – hospitals & clinics, ambulatory surgical centers, research & academic institutes, and others.

Regional Analysis of Global Cochlear Implants Market:

The U.S. accounted for the major market share owing to large demand, well-developed technology, high healthcare expenditure, and reimbursements. The large patient’s pool of37.5 million aged 18 and over representing over 15% of American adults add to the market. The presence of a number of leading players and faster uptake of technology add to the growth of the market.

Europe accounted for the second largest market led by Germany on account of its large medical device industry. Europe is followed by the Asia Pacific region led by Japan, South Korea, China and India. China and India are the future markets in Asia Pacific on basis of their growing economies and large unmet needs.

The Middle East & Africa is expected to generate moderate growth owing to the presence of poor socio-economic conditions. The Gulf economies of Saudi Arabia, UAE and Kuwait are expected to drive the market.

Get Prime Discount at https://www.marketresearchfuture.com/check-discount/5256 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: sales@marketresearchfuture.com
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: +1 646 845 9312

Source URL: https://marketersmedia.com/cochlear-implants-market-2018-to-perceive-illustrious-growth-usd-3203-8-million-with-cagr-of-9-86-by-2023/387024

For more information, please visit https://www.marketresearchfuture.com/reports/cochlear-implants-market-5256

Source: MarketersMedia

Release ID: 387024

Capillary Blood Collection Devices Market to Worth USD 778.38 Million with Booming CAGR of 10.0% by MRFR till 2023

Market Research Future published a cooked research report on “Capillary Blood Collection Devices Market” Research Report – By Major Industry Trends, Worldwide Business Analysis, Major Segments and Sub segments. Market Analysis, Scope, Stake, Progress and Forecast to 2023.

Pune, India – July 31, 2018 /MarketersMedia/

Capillary Blood Collection Devices Market – Highlight

Capillary Blood Collection Devices, the equipment used to collect the blood samplings for diagnosis and test purposes are integral to obtain high-quality clinical results. These devices are vastly preferred among clinicians and patients due to its simple and painless blood collection technique. 

Growing prevalence of chronic diseases and disorders such as vascular, diabetes, and heart diseases drive the market growth, increasing the demand for diagnosis and the uptake of these devices.  Resultantly, the global capillary blood collection devices market is garnering huge traction, growing pervasively.

Conversely, high prices of these devices is a predominant factor impeding the market growth. Also, the risk associated with the blood collection techniques and contaminations are hampering the market growth of the capillary blood collection devices market. Nevertheless, recent betterments taken place in these devices as a result of forays of the market players are increasing the demand for these devices by the physicians and patients, contributing to the market growth to a great extent, in turn.

Get Premium Sample Copy of Capillary Blood Collection Devices Market Report spread across 85 Premium Pages, Top 10 Companies and Supported with 105 Tables and 14 Figures is Now Available at https://www.marketresearchfuture.com/sample_request/4213

Key Players:

The leaders operating in the market include – Danaher Corporation, Abbott Laboratories, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Medtronic Plc., Novo Nordisk A S, Thermo Fisher Scientific Inc., etc.

Capillary Blood Collection Devices Market – Segments

The MRFR analysis is segmented into four key dynamics for the convenience of the report and enhanced understanding;

By Material s: Comprises Glass, Plastic, and Stainless Steel, among others.

By Types of Devices: Warming Devices, Blood Collecting Tubes & Collector, and Lancets, among others.

By End-Users: Hospitals, Clinics, Diagnostic Centers, Home Diagnostics, and Pathology Laboratories, among others.

By Regions: North America,   Europe, APAC and Rest-of-the-World.

The Plastic segment by the materials is projected to acquire 42.3% of the market share which will be the largest share. The segment will register 10.4% CAGR during the review period 2017–2023.

The Blood Collecting Tubes and Collector segment is expected to acquire 48.4% of the market share over the review period which will be the largest share based on the types of devices.

Capillary Blood Collection Devices Market – Regional Analysis

North America Capillary Blood Collection Devices Market backed by the presence of well-established players & investments, accounts for the leading market, globally, holding the largest market share. Companies involved in the manufacturing of these devices are well capable of delivering a range of customized solutions. Furthermore, augmented uptake of software solutions for healthcare administration and availability of complimenting resources drive the market growth in the region.

Factors substantiating the market growth include growing number of patients suffering from chronic diseases & disorders that consecutively augments the demand for diagnosis, increasing demand for technologically advanced diagnosis and treatment, rising government support and high per capita health care expenditures in the region. The market value is estimated to settle at US$ 292.96 Mn. by 2023.

The Europe market stands the second largest market for capillary blood collection devices, globally, owing to the technological advancement and the augmented adoption of these devices among the healthcare providers mainly in the UK, Germany, and France coupled with the resurging economy in the region which is improving the consumers’ quality of life by increasing their purchasing power.  

The Asia Pacific market stands the third position emerging as one of the promising markets for Capillary Blood Collection Devices. Factors such as, availability of new diagnosis and treatment methods, increasing prevalence of chronic diseases like diabetes and the growing population that is increasingly gaining awareness towards the benefits of health management, foster the market growth in the region.  The APAC market is estimated to grow at 10.6% CAGR during 2017–2023.

Capillary Blood Collection Devices Market – Competitive Landscape

The global market appears to be highly competitive and diversified with the presence of giant manufacturers of the devices, playing on the global level. These players are heavily investing in R&D, global expansion, advanced technologies and product Launch to gain the competitive edge in the market.

Get Prime Discount at https://www.marketresearchfuture.com/check-discount/4213

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: sales@marketresearchfuture.com
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: +1 646 845 9312

Source URL: https://marketersmedia.com/capillary-blood-collection-devices-market-to-worth-usd-778-38-million-with-booming-cagr-of-10-0-by-mrfr-till-2023/386919

For more information, please visit https://www.marketresearchfuture.com/reports/capillary-blood-collection-devices-market-4213

Source: MarketersMedia

Release ID: 386919

Saudi Arabia Medical Devices Market Assessment & Industry Forecast to Explore Ample Growth Opportunities Prophesy 2023

Market Research Future (MRFR) in its recently published study report asserts that the already booming Market of Saudi Arabia Medical Devices to analyze based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

Pune, India – July 31, 2018 /MarketersMedia/

A Medical Device is any instrument, appliance including any software, biologic or non-biologic material, to be used for the diagnostic or therapeutic use for management of diseases and disorders.

The developments in the region along with the country’s vision to enhance its offering in terms of the medical sector is boosting the demand for medical devices in the nation. Market focused reports linked with the healthcare industry among others recently have been made available by Market Research Future which issues reports on this industry. The market is anticipated to achieve $ 3870 million in revenues by the end of the forecast period while growing at a CAGR of 9.5 percent approximately in the forecast period.

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2801

Product developments and increased investment levels are powering the growth of the market considerably in the forecast period. Development of stronger and biocompatible materials is also significantly altering the growth of the market in the past few years. The progress of the diagnostic imaging sector is also observed to be motivating the market for medical devices in the upcoming forecast period.

The market constraints are strict and ambiguous regulatory framework, growing concern for security especially data security, differential availability between developed and developing regions, connectivity issues in Saudi Arabia, the interference Sharia courts etc.

The future developments will include cloud integration, connected healthcare devices and growing demand for personalized medical wearable devices. Healthcare mobile applications will also lead the market.

Saudi Arabia Medical Devices Market – Predominant Players

The major participants of this market are: Johnson & Johnson, General Electric, Medtronic, Koninklijke Philips Electronics NV., Baxter Internationa, Fresenius Medical Care AG & Co., Cardinal Health, Al-Salehiya Medical Estableshment, Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO), Al Amin Medical Instruments Company (AMICO), Al Faisaliah Medical Systems (FMS), Siemens Ltd and others.

Industry/Innovation/Related News:

May 16, 2018 – Informa Life Sciences Exhibitions (UK), a global organization, in charge of the healthcare portfolio and Global Exhibitions division, announced the Global Health Exhibition to be held from 10-12 September 2018 at the Riyadh International Convention and Exhibition Center, Saudi Arabia. One of the objectives of the exhibition is to avail Saudi Arabia’s leading healthcare platform to the global market to meet and network with Saudi healthcare sector’s pioneers and officials. More than 10,000 industry professionals across the globe are expected to explore the opportunities, along with the more than 500 Saudi-based and international exhibiting companies showcasing the latest advances in health services, pharmaceuticals, training and education, and medical device technologies.

Saudi Arabia Medical Devices Market – Segmentation

MRFR has segmented into 4 key dynamics for the convenience of the report and enhanced understanding;

By Product Types: Comprises Diagnostic Devices, Monitoring Devices, Diagnostic Molecular Devices, Surgical Devices, Drug Delivery Devices, Bio Implants and Stimulation Devices, Automation and Robotics among others.

By Therapeutic Applications: Diagnostic Imaging, General Surgery, Respiratory, Cardiovascular, Orthopaedics, Dental, Neurology, Ear-Nose-Throat (ENT), Ophthalmology, Nephrology and Urology, among others.

By End-Users: Ambulatory, Home and Hospitals among others.

By Regions: Geographical regions & Continents of Saudi Arabia

Saudi Arabia Medical Devices Market – Regional Analysis

The Healthcare Sector of Saudi Arabia is divided between private and state. The public healthcare expenditure accounts for approximately 75% of total health expenditure in 2014. Local manufacturing represents a poor outlook which is limited to consumables and ordinary articles. The government has established some of the best hospitals in the region such as King Faisal specialist hospital and research center, Riyadh military hospital, Saudi Arabia’s National Guard health affairs hospital etc. Saudi Arabia is extremely dependent on imports for medical devices and imports account for approximately 92% of total market for medical devices. U.S. medical device suppliers dominate the scenario with European vendors in the second position. Among the regions of Saudi Arabia Riyadh tops the healthcare expenditure list followed by Tabuk, Makkah and Madina.

Major Table of Content

1 Introduction

1.1 Definition

1.2 Scope of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure:

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

….Continued

To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/2801

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Info:
Name: Market Research Future
Organization: Market Research Future
Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: +1 646 845 9312

Source URL: https://marketersmedia.com/saudi-arabia-medical-devices-market-assessment-industry-forecast-to-explore-ample-growth-opportunities-prophesy-2023/387022

For more information, please visit https://www.marketresearchfuture.com/reports/saudi-arabia-medical-devices-market-2801

Source: MarketersMedia

Release ID: 387022

Allergy Immunotherapy Market Blatant Growth at USD 4,324.7 million with CAGR of 10.85% by MRFR – Outlook till 2023

Allergy Immunotherapy Market Report include on MarketReseacrhFuture.com with exhaustive Study. The report aims to provide an overview of Allergy Immunotherapy Market Report. The report provides key statistics on the market status. Global Forecast till 2023.

Pune, India – July 31, 2018 /MarketersMedia/

Market Scenario:

Market Research Future (MRFR) confirms that the global market for allergy immunotherapy is estimated to reach USD 4,324.7 million by 2023. MRFR also estimates that the market is set to grow phenomenally at the CAGR of 10.85% during the forecast period (2017–2023). The apparent market expansion can be accredited to rise in incidences of allergies across the globe. Growing awareness regarding allergy treatment and launch of new products boost the market growth imminently. Moreover, high prevalence of allergies cannot be tackled by pharmacotherapy alone, thus the need for allergy immunotherapy arises to curb this demand. Furthermore, this therapy increases immunological tolerance and alters the disease course, providing the long-term effect. These benefits account for its massive demand from all quarters of the world. Changing healthcare practices, growing healthcare expenditure and extended insurance cover provide the gist of the market expansion across the globe.

A restraining factor that can potentially impede the ongoing market growth includes occurrence of side effects after undergoing allergy immunotherapy. However, the success rate as compared to the negative effects is quite high making sure that the global market gains upward traction without any hiccups. Adding ammunition to this growth are growing clinical research and development (R&D) budget provided by governments and non-profit organizations.

Get Premium Sample Copy of Allergy Immunotherapy Market Report spread across 88 Premium Pages, Top 10 Companies and Supported with 65Tables and 35 Figures is Now Available at https://www.marketresearchfuture.com/sample_request/1517 .

Key Players:

The key players mentioned in the report are Stallergenes Greer (U.K.), Merck KGaA (Allergopharma) (Germany), ALK Abello A/S (Denmark), Allergy Therapeutics (U.K.), Circassia (U.K.), DBV Technologies (France), HAL Allergy Group (Netherlands), and others.

Market Segmentation:

The global allergy immunotherapy market is segmented on the basis of allergy type and treatment.

By allergy type, the market is segmented on the basis of allergic rhinitis, allergic asthma, peanut allergy, cat allergy, and other allergies. The allergic rhinitis segment has captured the largest market share in the global market whereas the peanut allergy segment is projected to grow at a competitive CAGR of 11.30% during the forecast period. High usage of tobacco, greater respiratory anomalies and rising demand for new treatments has led to the growth of the allergic rhinitis segment.

By treatment, the market is segmented on the basis of subcutaneous immunotherapy (SCIT), sublingual immunotherapy, and specific immunotherapy (SIT). Sublingual immunotherapy is sub-segmented into sublingual immunotherapy drops and sublingual immunotherapy tablets. The subcutaneous immunotherapy (SCIT) segment claims the largest market share in the global allergy immunotherapy market and is estimated to reach the value of USD 2,089.2 by 2023. Subcutaneous immunotherapy (SCIT) is highly favorable in the treatment of allergies as it provides symptomatic relief, at the same time modifying the allergic disease by targeting the underlying immunological mechanism.

Allergy Immunotherapy Market – Regional Analysis:

The global market is spread across North America, Asia Pacific, Europe and the Middle East & Africa.

As per observation, Europe is the largest contributor to the global market. Western Europe holds the largest market share and is projected to reach the value of USD 954.1 million by 2023. Increasing prevalence of chronic diseases such as allergy, asthma, diabetes and hypertension results in the market expansion in the region.

The North America market has exhibited a significant growth owing to high prevalence of allergic rhinitis & skin allergy along with growing awareness regarding treatment of allergies. The market in United States (US) was valued at USD 329.2 million in 2016. Worsening immunity, changing lifestyle, rapid industrialization and increasing number of smokers have also led to the market expansion in the region.

On the other hand, the region of Asia Pacific is experiencing rapid market growth on account of steadily growing awareness of treatments and rising healthcare expenditure. The market in Asia Pacific region is presumed to grow at a CAGR of 11.32% during the forecast period. Moreover, launch of sublingual immunotherapies in emerging economies in the region and introduction of several allergen immunotherapy tablets (AITs) by regional market players are leading to the market growth immensely.

Lastly, the Middle East & Africa market is expected to have restricted growth. However, United Arab Emirates (UAE) is leading the regional market by holding 53.5% of the total market share in the region. This is due to growing economy, increasing awareness about health-related issues and increasing healthcare infrastructure. Also, continuous strategic actions such as product launch and development, undertaken by regional market players establish the growth of the market significantly.

Industry News:

Global pharmaceutical company, ALK recently announced that its sublingual allergy immunotherapy (SLIT) tablet ODACTRA will be now available through prescription in the United States (US) for patients within the bracket of 18 years and 65 years of age, suffering from house dust mite (HDM)-induced allergic rhinitis. ODACTRA is a fast dissolving immunotherapy tablet to treat dust mite allergy and is also a new treatment option for physicians and patients. ODACTRA is the first HDM SLIT-tablet to be approved for use in the US.

Get Prime Discount at https://www.marketresearchfuture.com/enquiry/1517 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: sales@marketresearchfuture.com
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: +1 646 845 9312

Source URL: https://marketersmedia.com/allergy-immunotherapy-market-blatant-growth-at-usd-4324-7-million-with-cagr-of-10-85-by-mrfr-outlook-till-2023/386933

For more information, please visit https://www.marketresearchfuture.com/reports/allergy-immunotherapy-market-1517

Source: MarketersMedia

Release ID: 386933

Medical Automation Market 2018 Growth Analysis, Future Trends and Top Industry Players – Forecast to 2018 – 2023

Medical Automation Market Report include on MarketReseacrhFuture.com with exhaustive Study. The report aims to provide an overview of Medical Automation Market Report. The report provides key statistics on the market status. Global Forecast till 2023.

Pune, India – July 31, 2018 /MarketersMedia/

The Global Medical Automation Market is expected to grow at a CAGR of 7.0% during the forecast period. Medical automation is an emerging branch of the medical sector that is tended to evolve continuously in the presence of the technological advancements. Increasing prevalence of chronic diseases like cancer, diabetes, and others followed by the growing pharmaceutical and biotechnology sector are the major drivers for the market growth during the forecast period, 2017-2023. According to the Indian Brand Equity Foundation in 2017, the Indian biotech industry holds about 2% share of the global biotech industry. The biotechnology industry in India comprises of about 800 companies and is valued to be about USD 11.6 billion in 2017.

Get Premium Sample Copy of Medical Automation Market Report spread across 106 Premium Pages, Top 10 Companies and Supported with 123 Tables and 14 Figures is Now Available at https://www.marketresearchfuture.com/sample_request/5184 .

Additionally, rising demands for robotic surgery along with the rising healthcare expenditure boost the market growth. On the other hand, the high cost of automation, risks associated with the robotic surgery and the necessity for the physician training are estimated to restrain the market growth during the forecast period.

Medical Automation Market – Segmentation

The global medical automation market is segmented on the basis of type, and end users.

On the basis of type, the market is segmented into diagnostic & monitoring automation, therapeutic automation, lab & pharmacy automation, medical logistics & training, and others. The diagnostic & monitoring automation segment is sub-segmented into automated imaging, point-of-care testing (POCT), automated image analysis, and others. The therapeutic automation segment is sub-segmented into non-surgical automation, surgical automation, and others. The medical logistics & training segment is sub-segmented into logistic automation, trainers, and others.

On the basis of end users, the market is segmented into hospitals and diagnostic centers, pharmacies, research labs & institutes, research labs & institutes, and others.

Medical Automation Market – Competitive Landscape

The Global Medical Automation Market is highly competitive, and the key players operating in the market include Koninklijke Philips N.V., GENERAL ELECTRIC, Stryker, Accuray Incorporated, Siemens AG, Medtronic, Danaher, and others.

Industry Updates:

In June 2018, Siemens technology group announced a partnership with a supplier of the biopharmaceutical company, Sartorius Stedim Biotech (SSB) in the area of automation. Sartorius Stedim Biotech will use automation technology of Siemens for the biopharmaceuticals development and manufacture. The automation will facilitate greater scalability of processes.

In June 2018, a UK-based medical equipment developer, CRM Surgical collected funds from investors for commercializing its next-generation surgical robotic system. The financers include Zhejiang Silk Road Fund, Escala Capital Investments, Watrium, LGT and Cambridge Innovation Capital. The company will use the funds to complete validation studies for approval of the system.

Have any Query, Ask to Experts at https://www.marketresearchfuture.com/enquiry/5184 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Market Research Future
Email: sales@marketresearchfuture.com
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: +1 646 845 9312

Source URL: https://marketersmedia.com/medical-automation-market-2018-growth-analysis-future-trends-and-top-industry-players-forecast-to-2018-2023/387000

For more information, please visit https://www.marketresearchfuture.com/reports/medical-automation-market-5184

Source: MarketersMedia

Release ID: 387000

Free Pre-Market Technical Recap on DENTSPLY SIRONA and Three Additional Medical Supplies Stocks

Stock Research Monitor: ELGX, GKOS, and VLRX

LONDON, UK / ACCESSWIRE / July 31, 2018/ If you want a free Stock Review on XRAY sign up now at www.wallstequities.com/registration. On Monday, July 30, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged lower at the closing bell. Seven out of nine sectors ended Monday’s trading session in bearish territories. Taking into consideration yesterday’s market sentiment, WallStEquities.com assessed the following Medical Instruments & Supplies equities this morning: DENTSPLY SIRONA Inc. (NASDAQ: XRAY), Endologix Inc. (NASDAQ: ELGX), Glaukos Corp. (NYSE: GKOS), and Valeritas Holdings Inc. (NASDAQ: VLRX). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

DENTSPLY SIRONA

On Monday, shares in York, Pennsylvania headquartered DENTSPLY SIRONA Inc. recorded a trading volume of 1.58 million shares. The stock ended at $47.69, rising 0.87% from the last trading session. The Company’s shares have gained 9.28% in the last month. The stock is trading above its 50-day moving average by 5.75%. Furthermore, shares of DENTSPLY SIRONA, which designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide, have a Relative Strength Index (RSI) of 66.55. Get the full research report on XRAY for free by clicking below at:

www.wallstequities.com/registration/?symbol=XRAY

Endologix

Irvine, California headquartered Endologix Inc.’s stock finished yesterday’s session 0.20% lower at $4.91. A total volume of 269,546 shares was traded. The Company’s shares have gained 13.92% over the previous three months. The stock is trading below its 50-day moving average by 13.41%. Furthermore, shares of Endologix, which develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the US and internationally, have an RSI of 28.16. To experience our free membership services anytime/ anywhere and access the free report on ELGX, click to register at:

www.wallstequities.com/registration/?symbol=ELGX

Glaukos

At the close of trading on Monday, shares in San Clemente, California headquartered Glaukos Corp. saw a drop of 0.55%, ending the day at $39.55. The stock recorded a trading volume of 231,626 shares. The Company’s shares have advanced 17.43% in the previous three months. The stock is trading above its 200-day moving average by 20.67%. Moreover, shares of Glaukos, which focuses on the development and commercialization of surgical devices and sustained pharmaceutical therapies designed to treat glaucoma, have an RSI of 43.83. Join our big investor community at Wall St. Equities today and get your free report on GKOS at:

www.wallstequities.com/registration/?symbol=GKOS

Valeritas Holdings

Bridgewater, New Jersey headquartered Valeritas Holdings Inc.’s shares ended the day 3.31% lower at $1.46 with a total trading volume of 151,645 shares. The stock has gained 7.35% in the last month. The Company’s shares are trading below their 50-day moving average by 4.85%. Additionally, shares of Valeritas Holdings, which focuses on the development and commercialization of technologies to treat patients with Type-2 diabetes in the US and China, have an RSI of 47.18.

On July 05th, 2018, research firm Oppenheimer initiated an ‘Outperform’ rating on the Company’s stock, with a target price of $3.50 per share. Know more about VLRX in our free research coverage at:

www.wallstequities.com/registration/?symbol=VLRX

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com

Phone number: 21 32 044 483

Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities

ReleaseID: 507469